Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 2581461, 8 pages
http://dx.doi.org/10.1155/2016/2581461
Research Article

Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study

1Italian College of General Practitioners and Primary Care, Florence, Italy
2Department of Drug Sciences, University of Catania, Catania, Italy
3Bionap srl, R&D Contrada Fureria, Piano Tavola, 95032 Belpasso, Italy
4Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

Received 5 August 2016; Accepted 22 September 2016

Academic Editor: Raffaele Capasso

Copyright © 2016 Umberto Alecci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Vakil, S. V. van Zanten, P. Kahrilas et al., “The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus,” The American Journal of Gastroenterology, vol. 101, no. 8, pp. 1900–1920, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Moayyedi and N. J. Talley, “Gastro-oesophageal reflux disease,” The Lancet, vol. 367, no. 9528, pp. 2086–2100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Fass, “Proton pump inhibitor failure—what are the therapeutic options?” The American Journal of Gastroenterology, vol. 104, no. 2, pp. S33–S38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Hershcovici and R. Fass, “Nonerosive Reflux Disease (NERD)—an update,” Journal of Neurogastroenterology and Motility, vol. 16, no. 1, pp. 8–21, 2010. View at Publisher · View at Google Scholar
  5. H. B. El-Serag, “Epidemiology of non-erosive reflux disease,” Digestion, vol. 78, no. 1, pp. 6–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. M. Modlin, R. H. Hunt, P. Malfertheiner et al., “Diagnosis and management of non-erosive reflux disease—The vevey NERD consensus group,” Digestion, vol. 80, no. 2, pp. 74–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-W. Hu, Z.-G. Wang, Y. Zhang et al., “Gastroesophageal reflux in chronic cough and cough syncope and the effect of antireflux treatment: case report and literature review,” Annals of Otology, Rhinology & Laryngology, vol. 123, no. 10, pp. 719–725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kamolz, R. Pointner, and V. Velanovich, “The impact of gastroesophageal reflux disease on quality of life: review of the literature,” Surgical Endoscopy and Other Interventional Techniques, vol. 17, no. 8, pp. 1193–1199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Velanovich, “The development of the GERD-HRQL symptom severity instrument,” Diseases of the Esophagus, vol. 20, no. 2, pp. 130–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. El-Serag, A. Becher, and R. Jones, “Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies,” Alimentary Pharmacology and Therapeutics, vol. 32, no. 6, pp. 720–737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. A. Perry, T. H. Pham, S. J. Spechler, J. G. Hunter, W. S. Melvin, and V. Velanovich, “2014 SSAT state-of-the-art conference: advances in diagnosis and management of gastroesophageal reflux disease,” Journal of Gastrointestinal Surgery, vol. 19, no. 3, pp. 458–466, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. E. B. Lee, J. E. Hyun, D. W. Li, and Y. I. Moon, “Effects of Opuntia ficus-indica var. Saboten stem on gastric damages in rats,” Archives of Pharmacal Research, vol. 25, no. 1, pp. 67–70, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Dekanski, S. Janićijević-Hudomal, S. Ristić et al., “Attenuation of cold restraint stress-induced gastric lesions by an olive leaf extract,” General Physiology and Biophysics, vol. 28, pp. 135–142, 2009. View at Google Scholar · View at Scopus
  14. C.-T. Chiu, C.-M. Hsu, C.-C. Wang et al., “Randomised clinical trial: Sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease,” Alimentary Pharmacology and Therapeutics, vol. 38, no. 9, pp. 1054–1064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Pouchain, M.-A. Bigard, F. Liard, M. Childs, A. Decaudin, and D. McVey, “Gaviscon vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. A direct comparative randomised trial,” BMC Gastroenterology, vol. 12, article 18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Velanovich, S. R. Vallance, J. R. Gusz, F. V. Tapia, and M. A. Harkabus, “Quality of life scale for gastroesophageal reflux disease,” Journal of the American College of Surgeons, vol. 183, no. 3, pp. 217–224, 1996. View at Google Scholar · View at Scopus
  17. A. Damiano, K. Handley, E. Adler, R. Siddique, and A. Bhattacharyja, “Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: Further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS),” Digestive Diseases and Sciences, vol. 47, no. 7, pp. 1530–1537, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ronkainen, P. Aro, T. Storskrubb et al., “High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda Study Report,” Scandinavian Journal of Gastroenterology, vol. 40, no. 3, pp. 275–285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. A. Drossman, E. Corazziari, M. Delvaux et al., Rome III. The Functional Gastrointestinal Disorders, Degnon Associates, McLean, Va, USA, 2006.
  20. G. Holtmann, P. Bytzer, M. Metz, V. Loeffler, and A. L. Blum, “A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 3, pp. 479–485, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. Galmiche, F. Zerbib, P. Ducrottè et al., “Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole,” Alimentary Pharmacology and Therapeutics, vol. 15, no. 9, pp. 1343–1350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Miner Jr., W. Orr, J. Filippone, L. Jokubaitis, and S. Sloan, “Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial,” American Journal of Gastroenterology, vol. 97, no. 6, pp. 1332–1339, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Rothman, C. Farup, W. Stewart, L. Helbers, and J. Zeldis, “Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials,” Digestive Diseases and Sciences, vol. 46, no. 7, pp. 1540–1549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Chassany, G. Holtmann, J. Malagelada, U. Gebauer, H. Doerfler, and K. Devault, “Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease,” Alimentary Pharmacology and Therapeutics, vol. 27, no. 11, pp. 1053–1070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Fitzpatrick, S. Ziebland, C. Jenkinson, A. Mowat, and A. Mowat, “Importance of sensitivity to change as a criterion for selecting health status measures,” Quality in Health Care, vol. 1, no. 2, pp. 89–93, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. G. P. Young, G. S. Nagy, J. Myren et al., “Treatment of reflux oesophagitis with a carbenoxolone/ antacid/alginate preparation: a double-blind controlled trial,” Scandinavian Journal of Gastroenterology, vol. 21, no. 9, pp. 1098–1104, 1986. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Manabe, K. Haruma, M. Ito et al., “Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial,” Diseases of the Esophagus, vol. 25, no. 5, pp. 373–380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Greally, F. J. Hampton, U. M. MacFadyen, and H. Simpson, “Gaviscon and Carobel compared woth cisapride in gastro-oesophageal reflux,” Archives of Disease in Childhood, vol. 67, no. 5, pp. 618–621, 1992. View at Publisher · View at Google Scholar
  29. T. Satapathy, P. K. Panda, A. K. Goyal, and G. Rath, “Evaluation of anti-GERD activity of gastro retentive drug delivery system of itopride hydrochloride,” Artificial Cells, Blood Substitutes, and Biotechnology, vol. 38, no. 4, pp. 200–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Prajapati, A. Mehta, I. Modhia, and C. Patel, “Formulation and optimisation of raft- forming chewable tablets containing H2 antagonist,” International Journal of Pharmaceutical Investigation, vol. 2, no. 4, pp. 176–182, 2012. View at Publisher · View at Google Scholar
  31. P. K. Singh and I. P. Kaur, “Synbiotic (probiotic and ginger extract) loaded floating beads: a novel therapeutic option in an experimental paradigm of gastric ulcer,” Journal of Pharmacy and Pharmacology, vol. 64, no. 2, pp. 207–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. E. M. Galati, S. Pergolizzi, N. Miceli, M. T. Monforte, and M. M. Tripodo, “Study on the increment of the production of gastric mucus in rats treated with Opuntia ficus indica (L.) Mill. cladodes,” Journal of Ethnopharmacology, vol. 83, no. 3, pp. 229–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. E. M. Galati, M. R. Mondello, D. Giuffrida et al., “Chemical characterization and biological effects of sicilian Opuntia ficus indica (L.) Mill. fruit juice: antioxidant and antiulcerogenic activity,” Journal of Agricultural and Food Chemistry, vol. 51, no. 17, pp. 4903–4908, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Trachtenberg and A. M. Mayer, “Biophysical properties of Opuntia ficus-indica mucilage,” Phytochemistry, vol. 21, no. 12, pp. 2835–2843, 1980. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Butterweck, L. Semlin, B. Feistel, I. Pischel, K. Bauer, and E. J. Verspohl, “Comparative evaluation of two different Opuntia ficus-indica extracts for blood sugar lowering effects in rats,” Phytotherapy Research, vol. 25, no. 3, pp. 370–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. N. El and S. Karakaya, “Olive tree (Olea europaea) leaves: potential beneficial effects on human health,” Nutrition Reviews, vol. 67, no. 11, pp. 632–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. M. Bitler, T. M. Viale, B. Damaj, and R. Crea, “Hydrolyzed olive vegetation water in mice has anti-inflammatory activity,” The Journal of Nutrition, vol. 135, no. 6, pp. 1475–1479, 2005. View at Google Scholar · View at Scopus
  38. V. Goulas, V. T. Papoti, V. Exarchou, M. Z. Tsimidou, and I. P. Gerothanassis, “Contribution of flavonoids to the overall radical scavenging activity of olive (Olea europaea L.) leaf polar extracts,” Journal of Agricultural and Food Chemistry, vol. 58, no. 6, pp. 3303–3308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Serrilli, G. Frasca, L. Rizza, F. P. Bonina, and A. Bianco, “Nocellaralactone, a new monoterpenoid with anti-inflammatory activity, from Olea europaea L., cultivar Nocellara del Belice,” Natural Product Research, vol. 27, no. 24, pp. 2311–2319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Venditti, A. M. Serrilli, L. Rizza et al., “Aromadendrine, a new component of the flavonoid pattern of Olea europaea L. and its anti-inflammatory activity,” Natural Product Research, vol. 27, no. 4-5, pp. 340–349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Rizza, G. Frasca, M. Nicholls, C. Puglia, and V. Cardile, “Caco-2 cell line as a model to evaluate mucoprotective proprieties,” International Journal of Pharmaceutics, vol. 422, no. 1-2, pp. 318–322, 2012. View at Publisher · View at Google Scholar · View at Scopus